Loading…
Noninvasive assessment of liver damage in chronic hepatitis B
AIM:To evaluate the efficacy of the aspartate aminotransferase/platelet ratio index(APRI)and neutrophillymphocyte(N/L)ratio to predict liver damage in chronic hepatitis B(CHB).METHODS:We analyzed 89 patients diagnosed with CHB by percutaneous liver biopsy and 43 healthy subjects.Liver biopsy materia...
Saved in:
Published in: | World journal of hepatology 2013-08, Vol.5 (8), p.439-444 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353 |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353 |
container_end_page | 444 |
container_issue | 8 |
container_start_page | 439 |
container_title | World journal of hepatology |
container_volume | 5 |
creator | Celikbilek, Mehmet |
description | AIM:To evaluate the efficacy of the aspartate aminotransferase/platelet ratio index(APRI)and neutrophillymphocyte(N/L)ratio to predict liver damage in chronic hepatitis B(CHB).METHODS:We analyzed 89 patients diagnosed with CHB by percutaneous liver biopsy and 43 healthy subjects.Liver biopsy materials were stained with hematoxylin-eosin and Masson’s trichrome.Patients’fibrosis scores and histological activity index(HAI)were calculated according to the Ishak scoring system.Fibrosis score was recognized as follows:F0-1 No/early-stage fibrosis,F2-6 significant fibrosis,F0-4 non-cirrhotic and F5-6 cirrhotic.Significant liver fibrosis was defined as an Ishak score of≥2.APRI and N/L ratio calculation was made by blood test results.RESULTS:The hepatitis B and control group showed no difference in N/L ratios while there was a significant difference in terms of APRI scores(P<0.001).Multiple logistic regression analysis revealed that the only independent predictive factor for liver fibrosis in CHB was platelet count.APRI score was significantly higher in cirrhotic patients than in non-cirrhotic patients.However,this significance was not confirmed by multiple logistic regression analysis.The optimum APRI score cut-off point to identify patients with cirrhosis was 1.01with sensitivity,specificity,positive predictive value and negative predictive value of 62%(36%-86%),74%(62%-83%),29%(13%-49%)and 92%(82%-97%),respectively.In addition,correlation analyses revealed that N/L ratio has a negative and significant relationship with HAI(r=-0.218,P=0.041).CONCLUSION:N/L ratio was negatively correlated with HAI.APRI score may be useful to exclude cirrhosis in CHB patients. |
doi_str_mv | 10.4254/wjh.v5.i8.439 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3767843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>1003031611</cqvip_id><sourcerecordid>1432075284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353</originalsourceid><addsrcrecordid>eNpVkM1LwzAYh4MoTuaOXqXgxUtrPtv0oKDDLxh60XNI0qTN6MfWdBX_eyObY-aS8ObheX_8ALhAMKGY0ZuvZZWMLHE8oSQ_AmcopzxmiOPjg_cEzLxfwnAoTXPOT8EEU4hJzskZuH3rWteO0rvRRNJ7431j2iHqbFSHUR8VspGliVwb6aoPrI4qs5KDG5yPHs7BiZW1N7PdPQWfT48f85d48f78Or9fxJoiNsSaY61SluEiU0WmM854qlSKrNUmxVAXOGAWaa4QzC0t8gxCaXMDFU6xIoxMwd3Wu9qoxhQ6JOxlLVa9a2T_LTrpxP-f1lWi7EZBsjTjlATB9U7Qd-uN8YNonNemrmVruo0XiBIMM4YDOwXxFtV9531v7H4NguK3dRFaFyMTjovQeuAvD7Pt6b-OA3C1E1ZdW65dWx4YIYEEpQiRH3RliwQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1432075284</pqid></control><display><type>article</type><title>Noninvasive assessment of liver damage in chronic hepatitis B</title><source>PubMed Central (Open Access)</source><creator>Celikbilek, Mehmet</creator><creatorcontrib>Celikbilek, Mehmet</creatorcontrib><description>AIM:To evaluate the efficacy of the aspartate aminotransferase/platelet ratio index(APRI)and neutrophillymphocyte(N/L)ratio to predict liver damage in chronic hepatitis B(CHB).METHODS:We analyzed 89 patients diagnosed with CHB by percutaneous liver biopsy and 43 healthy subjects.Liver biopsy materials were stained with hematoxylin-eosin and Masson’s trichrome.Patients’fibrosis scores and histological activity index(HAI)were calculated according to the Ishak scoring system.Fibrosis score was recognized as follows:F0-1 No/early-stage fibrosis,F2-6 significant fibrosis,F0-4 non-cirrhotic and F5-6 cirrhotic.Significant liver fibrosis was defined as an Ishak score of≥2.APRI and N/L ratio calculation was made by blood test results.RESULTS:The hepatitis B and control group showed no difference in N/L ratios while there was a significant difference in terms of APRI scores(P&lt;0.001).Multiple logistic regression analysis revealed that the only independent predictive factor for liver fibrosis in CHB was platelet count.APRI score was significantly higher in cirrhotic patients than in non-cirrhotic patients.However,this significance was not confirmed by multiple logistic regression analysis.The optimum APRI score cut-off point to identify patients with cirrhosis was 1.01with sensitivity,specificity,positive predictive value and negative predictive value of 62%(36%-86%),74%(62%-83%),29%(13%-49%)and 92%(82%-97%),respectively.In addition,correlation analyses revealed that N/L ratio has a negative and significant relationship with HAI(r=-0.218,P=0.041).CONCLUSION:N/L ratio was negatively correlated with HAI.APRI score may be useful to exclude cirrhosis in CHB patients.</description><identifier>ISSN: 1948-5182</identifier><identifier>EISSN: 1948-5182</identifier><identifier>DOI: 10.4254/wjh.v5.i8.439</identifier><identifier>PMID: 24023983</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>Brief ; Chronic ; cirrhosis ; Fibrosis ; hepatitis ; Liver ; markers ; Noninvasive ; Serum</subject><ispartof>World journal of hepatology, 2013-08, Vol.5 (8), p.439-444</ispartof><rights>2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353</citedby><cites>FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/71422X/71422X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767843/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767843/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24023983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Celikbilek, Mehmet</creatorcontrib><title>Noninvasive assessment of liver damage in chronic hepatitis B</title><title>World journal of hepatology</title><addtitle>World Journal of Hepatology</addtitle><description>AIM:To evaluate the efficacy of the aspartate aminotransferase/platelet ratio index(APRI)and neutrophillymphocyte(N/L)ratio to predict liver damage in chronic hepatitis B(CHB).METHODS:We analyzed 89 patients diagnosed with CHB by percutaneous liver biopsy and 43 healthy subjects.Liver biopsy materials were stained with hematoxylin-eosin and Masson’s trichrome.Patients’fibrosis scores and histological activity index(HAI)were calculated according to the Ishak scoring system.Fibrosis score was recognized as follows:F0-1 No/early-stage fibrosis,F2-6 significant fibrosis,F0-4 non-cirrhotic and F5-6 cirrhotic.Significant liver fibrosis was defined as an Ishak score of≥2.APRI and N/L ratio calculation was made by blood test results.RESULTS:The hepatitis B and control group showed no difference in N/L ratios while there was a significant difference in terms of APRI scores(P&lt;0.001).Multiple logistic regression analysis revealed that the only independent predictive factor for liver fibrosis in CHB was platelet count.APRI score was significantly higher in cirrhotic patients than in non-cirrhotic patients.However,this significance was not confirmed by multiple logistic regression analysis.The optimum APRI score cut-off point to identify patients with cirrhosis was 1.01with sensitivity,specificity,positive predictive value and negative predictive value of 62%(36%-86%),74%(62%-83%),29%(13%-49%)and 92%(82%-97%),respectively.In addition,correlation analyses revealed that N/L ratio has a negative and significant relationship with HAI(r=-0.218,P=0.041).CONCLUSION:N/L ratio was negatively correlated with HAI.APRI score may be useful to exclude cirrhosis in CHB patients.</description><subject>Brief</subject><subject>Chronic</subject><subject>cirrhosis</subject><subject>Fibrosis</subject><subject>hepatitis</subject><subject>Liver</subject><subject>markers</subject><subject>Noninvasive</subject><subject>Serum</subject><issn>1948-5182</issn><issn>1948-5182</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LwzAYh4MoTuaOXqXgxUtrPtv0oKDDLxh60XNI0qTN6MfWdBX_eyObY-aS8ObheX_8ALhAMKGY0ZuvZZWMLHE8oSQ_AmcopzxmiOPjg_cEzLxfwnAoTXPOT8EEU4hJzskZuH3rWteO0rvRRNJ7431j2iHqbFSHUR8VspGliVwb6aoPrI4qs5KDG5yPHs7BiZW1N7PdPQWfT48f85d48f78Or9fxJoiNsSaY61SluEiU0WmM854qlSKrNUmxVAXOGAWaa4QzC0t8gxCaXMDFU6xIoxMwd3Wu9qoxhQ6JOxlLVa9a2T_LTrpxP-f1lWi7EZBsjTjlATB9U7Qd-uN8YNonNemrmVruo0XiBIMM4YDOwXxFtV9531v7H4NguK3dRFaFyMTjovQeuAvD7Pt6b-OA3C1E1ZdW65dWx4YIYEEpQiRH3RliwQ</recordid><startdate>20130827</startdate><enddate>20130827</enddate><creator>Celikbilek, Mehmet</creator><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130827</creationdate><title>Noninvasive assessment of liver damage in chronic hepatitis B</title><author>Celikbilek, Mehmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Brief</topic><topic>Chronic</topic><topic>cirrhosis</topic><topic>Fibrosis</topic><topic>hepatitis</topic><topic>Liver</topic><topic>markers</topic><topic>Noninvasive</topic><topic>Serum</topic><toplevel>online_resources</toplevel><creatorcontrib>Celikbilek, Mehmet</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Celikbilek, Mehmet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noninvasive assessment of liver damage in chronic hepatitis B</atitle><jtitle>World journal of hepatology</jtitle><addtitle>World Journal of Hepatology</addtitle><date>2013-08-27</date><risdate>2013</risdate><volume>5</volume><issue>8</issue><spage>439</spage><epage>444</epage><pages>439-444</pages><issn>1948-5182</issn><eissn>1948-5182</eissn><abstract>AIM:To evaluate the efficacy of the aspartate aminotransferase/platelet ratio index(APRI)and neutrophillymphocyte(N/L)ratio to predict liver damage in chronic hepatitis B(CHB).METHODS:We analyzed 89 patients diagnosed with CHB by percutaneous liver biopsy and 43 healthy subjects.Liver biopsy materials were stained with hematoxylin-eosin and Masson’s trichrome.Patients’fibrosis scores and histological activity index(HAI)were calculated according to the Ishak scoring system.Fibrosis score was recognized as follows:F0-1 No/early-stage fibrosis,F2-6 significant fibrosis,F0-4 non-cirrhotic and F5-6 cirrhotic.Significant liver fibrosis was defined as an Ishak score of≥2.APRI and N/L ratio calculation was made by blood test results.RESULTS:The hepatitis B and control group showed no difference in N/L ratios while there was a significant difference in terms of APRI scores(P&lt;0.001).Multiple logistic regression analysis revealed that the only independent predictive factor for liver fibrosis in CHB was platelet count.APRI score was significantly higher in cirrhotic patients than in non-cirrhotic patients.However,this significance was not confirmed by multiple logistic regression analysis.The optimum APRI score cut-off point to identify patients with cirrhosis was 1.01with sensitivity,specificity,positive predictive value and negative predictive value of 62%(36%-86%),74%(62%-83%),29%(13%-49%)and 92%(82%-97%),respectively.In addition,correlation analyses revealed that N/L ratio has a negative and significant relationship with HAI(r=-0.218,P=0.041).CONCLUSION:N/L ratio was negatively correlated with HAI.APRI score may be useful to exclude cirrhosis in CHB patients.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>24023983</pmid><doi>10.4254/wjh.v5.i8.439</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1948-5182 |
ispartof | World journal of hepatology, 2013-08, Vol.5 (8), p.439-444 |
issn | 1948-5182 1948-5182 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3767843 |
source | PubMed Central (Open Access) |
subjects | Brief Chronic cirrhosis Fibrosis hepatitis Liver markers Noninvasive Serum |
title | Noninvasive assessment of liver damage in chronic hepatitis B |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T09%3A31%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noninvasive%20assessment%20of%20liver%20damage%20in%20chronic%20hepatitis%20B&rft.jtitle=World%20journal%20of%20hepatology&rft.au=Celikbilek,%20Mehmet&rft.date=2013-08-27&rft.volume=5&rft.issue=8&rft.spage=439&rft.epage=444&rft.pages=439-444&rft.issn=1948-5182&rft.eissn=1948-5182&rft_id=info:doi/10.4254/wjh.v5.i8.439&rft_dat=%3Cproquest_pubme%3E1432075284%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-c82cb6572d7bd7c78586bb61ffce620cd2415f1c8b109f4d9700af9e0b262b353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1432075284&rft_id=info:pmid/24023983&rft_cqvip_id=1003031611&rfr_iscdi=true |